The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from Business Wire

Illumina to Webcast Live Presentations at Upcoming Investment Conferences in September

Tuesday, September 04, 2012

Illumina to Webcast Live Presentations at Upcoming Investment Conferences in September06:30 EDT Tuesday, September 04, 2012 SAN DIEGO (Business Wire) -- Illumina, Inc. (NASDAQ:ILMN) today announced that it will webcast the Company's presentations at two upcoming investment conferences. Illumina will webcast its presentation at the Morgan Stanley Global Healthcare Conference in New York, New York on September 11, 2012. The live webcast is scheduled to begin at 10:20 a.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer, followed by a question and answer session. Illumina will also webcast its presentation at the UBS Global Life Sciences Conference in New York, New York on September 19, 2012. The live webcast is scheduled to begin at 9:30 a.m. ET and will feature an overview of the company by Jay Flatley, President and Chief Executive Officer, followed by a question and answer session. These webcasts can be accessed in the Investor Relations section of Illumina's web site under the "Company" tab at www.illumina.com. About Illumina Illumina (www.illumina.com) is a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function. We provide innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies, gene expression profiling, and low-multiplex analysis of DNA, RNA, and protein. We also provide tools and services that are fueling advances in consumer genomics and diagnostics. Our technology and products accelerate genetic analysis research and its application, paving the way for molecular medicine and ultimately transforming healthcare. Illumina, Inc.Investors:Scott Dawson, 858-882-6665sdawson@illumina.comorMedia:Jennifer Temple, 858-882-6822pr@illumina.com